Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1366551 | Bioorganic & Medicinal Chemistry Letters | 2007 | 4 Pages |
Abstract
Introduction of 3-substituted azetidinyl substituents onto the 4,6-diaminopyrimidine scaffold allowed the improvement of PDE4 inhibiting activities. Preliminary in vivo activity in pulmonary inflammation models is reported.
Graphical abstractThe SAR around 3-substituted azetidinylpyrimidine derivatives as potent dual M3 antagonists and PDE4 inhibitors is reported.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Laurent Provins, Bernard Christophe, Pierre Danhaive, Jacques Dulieu, Michel Gillard, Luc Quéré, Karin Stebbins,